Monthly lectures in translational science. Thought leaders in neurology, psychology, biology, neuroscience and more delivering interdisciplinary lectures to your doorstep.
Join CPD and esteemed speakers for lunch & learn sessions (12pm-1pm) at at the Ruffato Hall Commons, at Morgridge College of Education on the corner of Evans Ave. and High St.
Brain Rounds are free! No pre-registration necessary, come one - come all!
Hungry? Check out the food truck which will be parked outside during each session!
Brain rounds are FREE and open to the public, 1.0 CE credit is available for $30.
Wednesday May 18th, 2016 - Saj Razvi, MA, LPC,
Co-investigator on the FDA study of MDMA-assisted psychotherapy for treatment-resistant PTSD. Hear about the newest research on the utility of psychedelic medications in clinical practice.
MDMA-Assisted Psychotherapy for Treatment-Resistant PTSD
Find out more about this Brain Round
Post-Traumatic Stress Disorder (PTSD) is being called one of the biggest mental health challenges facing our country. Join Saj Razvi, Executive Director of Trauma Dynamics, as he shares insights and results from the Phase 2 FDA clinical trial of MDMA-assisted psychotherapy for which he is a clinical sub-investigator. MDMA, first used in psychotherapy before it was coopted as the street drug Ecstasy, has strong evidence indicating it's a powerful resource for resolving treatment-resistant PTSD.
Interested in learning more about this topic? Check out the Trauma Dynamic One-Day Workshop!!
Saj Razvi is the Executive Director of Trauma Dynamics. He is a licensed psychotherapist and leads Trauma Dynamics trainings nationally for therapists, graduate students, and medical professionals. He is a sub-investigator for the FDA clinical study of MDMA-Assisted Psychotherapy for Treatment-Resistant PTSD. Saj is also a national topic expert and speaker for PESI Education focusing on complex PTSD, and he runs a trauma education program at the University of Colorado Hospital's CeDAR addiction treatment center and the University of Denver's Center for Professional Development. Saj is co-author of a soon-to-be-released text for therapists that is based on the Trauma Dynamics treatment protocol.
Learn about previous Brain Round sessions!
Wednesday January 13, 2016 Adam Hebb, M.D.
FIND OUT MORE ABOUT THIS SESSION
Physician & Research Associate, Colorado Neurological Institute. Neurosurgeon at the Colorado Brain and Spine Institute and Assistant Professor at the University of Denver.
Innovations in Human Brain Stimulation
About the Speaker:
Dr. Hebb is a neurosurgeon specializing in neuro-oncology and functional neurosurgery, including deep brain stimulation. He is dual board certified by the American Board of Neurological Surgery and the Royal College of Physicians and Surgeons of Canada. Dr. Hebb's research is focused on developing novel techniques to improve the quality of life for patients with neurological disease. His research laboratory has two primary focuses that utilize neurophysiological recordings of human brain signals. One focus is designed to determine the relationship between brain signals and normal human behavior, in order to customize neurostimulation based on predicted behavior in a closed loop system. The other focus area is the analysis of brain signals recorded from different regions, including subcortical local field potentials and electrocorticography, to determine the pattern of brain connectivity using measures of neuronal synchrony.
During Dr. Hebb's medical training at Dalhousie University in Canada, he studied cellular therapies for Parkinson's disease, supported by the Parkinson's Disease Foundation and a studentship in neurodegenerative disorders. While in neurosurgical residency at the University of Minnesota, he was awarded the Zhao Zi-Zhen Neurosurgery Resident Award for clinical and operative skill, research excellence, and humanism as a physician and surgeon. Dr. Hebb then completed fellowship training in neuro-oncology and epilepsy surgery at the University of Washington. Dr. Hebb's research in epilepsy was supported by the Epilepsy Foundation and the William Gowers Clinical Research Fellowship. After training, Dr. Hebb joined the University of Washington where he led an education course leading neurosurgical trainees to success in their academic examinations. Dr. Hebb is affiliated with the Colorado Neurological Institute where he leads a laboratory in clinical human neuroscience and neuromodulation.
- Discuss the history and mechanism of action for deep brain stimulation as a treatment for movement disorders.
- Discuss new frontiers in deep brain stimulation including customization of therapy to patient's momen t to moment goals.
Wednesday February 10, 2016 Lotta Granholm, PhD.
Find out more about this session
Ann-Charlotte (“Lotta”) Granholm joined the University of Denver on Sept. 1 as the founding executive director of the Knoebel Institute for Healthy Aging. Granholm is also a research professor in the Department of Biological Sciences. She comes to DU after 14 years as the director of the Center on Aging at the Medical University of South Carolina. Granholm recently received a three-year appointment as a guest professor in neurosciences at the Karolinska Institute in Stockholm. One of the largest and most prestigious medical universities in the world, Karolinska is the premier research institute in Sweden and the university that gives out the Nobel Prize in Medicine (official name: Nobel Prize in medicine or physiology).
About the talk
Down syndrome (DS) is the most common genetic condition, with about 1 in 700 babies born in the US. Because people with DS have increased their life span significantly the last couple of decades, they now live well into their 60s and 70s. Because of several genes located on the human chromosome 21, which is triplicated in DS, those with DS exhibit Alzheimer’s disease pathology already in their 20s, and are highly susceptible to dementia later in life. This talk will focus on data obtained from mouse models of DS as well as humans with DS, and we will focus on potential treatment strategies and biological mechanisms.
1. Understand biological mechanisms for Alzheimer in DS (DS-AD)2. Learn about novel treatment options
Wednesday March 30, 2016 - Michael Pearlman, M.D., PhD.
FIND OUT MORE ABOUT THIS SESSION
President, Medical Advisory Council, Colorado Neurological Institute. Specializes in neuro-oncology and pediatric neurology.
Advances in Neuroscience and Oncology
Wednesday April 20, 2016 – Dan Linseman, PhD.
FIND OUT MORE ABOUT THIS SESSION
Research Associate Colorado Neurological Institute and associate professor/researcher at the University of Denver focusing on natural products, nutraceuticals, and nutritional supplements as therapeutic agents for neurodegenerative diseases and neurotrauma
These programs are approved for 1.0 hour of continuing education. The University of Denver, Graduate School of Professional Psychology (GSPP) is approved by the American Psychological Association to sponsor continuing education for psychologists. GSPP maintains responsibility for this program and its content.
For information and questions contact Shannon Gray, CPD Assistant Director, at Shannon.Gray@du.edu or 303.871.4161